Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response - PubMed (original) (raw)
Comparative Study
. 2007 Feb 27;177(2):205-13.
doi: 10.1016/j.bbr.2006.11.032. Epub 2006 Dec 27.
Affiliations
- PMID: 17194489
- DOI: 10.1016/j.bbr.2006.11.032
Comparative Study
Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response
Rui D S Prediger et al. Behav Brain Res. 2007.
Abstract
Considerable evidence supports the role of oxidative stress in the pathogenesis of Alzheimer's disease (AD). Previous studies suggest that the central nervous system (CNS) administration of beta-amyloid peptide, the major constituent of senile plaque in AD, induces oxidative stress in rodents which may contribute to the learning and memory deficits verified in the beta-amyloid model of AD. In the present study, we compared the effects of a single intracerebroventricular (i.c.v.) injection of aggregated beta-amyloid peptide-(1-40) (Abeta(1-40)) (400pmol/mouse) on spatial learning and memory performance, synaptic density and the glutathione (GSH)-dependent antioxidant status in adult male C57BL/6 and Swiss albino mice. Seven days after Abeta(1-40) administration, C57BL/6 and Swiss mice presented similar spatial learning and memory impairments, as evaluated in the water maze task, although these impairments were not found in Abeta(40-1)-treated mice. Moreover, a similar decline of synaptophysin levels was observed in the hippocampus (HC) and prefrontal cortex (PFC) of both Swiss and C57BL/6 mice treated with Abeta(1-40), which suggests synaptic loss. C57BL/6 mice presented lower levels of glutathione-related antioxidant defences (total glutathione (GSH-t) levels, glutathione peroxidase (GPx) and glutathione reductase (GR) activity) in the HC and PFC in comparison to Swiss mice. Despite the reduced basal GSH-dependent antioxidant defences observed in C57BL/6 mice, Abeta(1-40) administration induced significant alterations in the brain antioxidant parameters only in Swiss mice, decreasing GSH-t levels and increasing GPx and GR activity in the HC and PFC 24h after treatment. These results indicate strain differences in the susceptibility to Abeta(1-40)-induced changes in the GSH-dependent antioxidant defences in mice, which should be taken into account in further studies using the Abeta model of AD in mice. In addition, the present findings suggest that the spatial learning and memory deficits induced by beta-amyloid peptides in rodents may not be entirely related to glutathione-dependent antioxidant response.
Similar articles
- Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
Jhoo JH, Kim HC, Nabeshima T, Yamada K, Shin EJ, Jhoo WK, Kim W, Kang KS, Jo SA, Woo JI. Jhoo JH, et al. Behav Brain Res. 2004 Dec 6;155(2):185-96. doi: 10.1016/j.bbr.2004.04.012. Behav Brain Res. 2004. PMID: 15364477 - Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD, Medeiros R, Pandolfo P, Duarte FS, Passos GF, Pesquero JB, Campos MM, Calixto JB, Takahashi RN. Prediger RD, et al. Neuroscience. 2008 Feb 6;151(3):631-43. doi: 10.1016/j.neuroscience.2007.11.009. Epub 2007 Nov 17. Neuroscience. 2008. PMID: 18191900 - Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z. Sipos E, et al. Neuroscience. 2007 Jun 15;147(1):28-36. doi: 10.1016/j.neuroscience.2007.04.011. Epub 2007 May 17. Neuroscience. 2007. PMID: 17499931 - Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, LaFerla FM, Fernández-Teruel A. Giménez-Llort L, et al. Neurosci Biobehav Rev. 2007;31(1):125-47. doi: 10.1016/j.neubiorev.2006.07.007. Epub 2006 Oct 20. Neurosci Biobehav Rev. 2007. PMID: 17055579 Review. - Molecular mechanism of cholinergic dysfunction and cognitive deficits induced by amyloid beta-peptide.
Tran MH, Yamada K, Nabeshima T. Tran MH, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2001 Oct;21(4):125-32. Nihon Shinkei Seishin Yakurigaku Zasshi. 2001. PMID: 11769570 Review.
Cited by
- Neuroprotective effect of physical exercise in a mouse model of Alzheimer's disease induced by β-amyloid₁₋₄₀ peptide.
Souza LC, Filho CB, Goes AT, Fabbro LD, de Gomes MG, Savegnago L, Oliveira MS, Jesse CR. Souza LC, et al. Neurotox Res. 2013 Aug;24(2):148-63. doi: 10.1007/s12640-012-9373-0. Epub 2013 Jan 11. Neurotox Res. 2013. PMID: 23307759 - The Dual Role of Kinin/Kinin Receptors System in Alzheimer's Disease.
Ji B, Wang Q, Xue Q, Li W, Li X, Wu Y. Ji B, et al. Front Mol Neurosci. 2019 Oct 1;12:234. doi: 10.3389/fnmol.2019.00234. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31632239 Free PMC article. - Effects of sulforaphane on cognitive function in patients with frontal brain damage: study protocol for a randomised controlled trial.
Liu F, Huang J, Hei G, Wu R, Liu Z. Liu F, et al. BMJ Open. 2020 Oct 16;10(10):e037543. doi: 10.1136/bmjopen-2020-037543. BMJ Open. 2020. PMID: 33067279 Free PMC article. - Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.
Suganthy N, Malar DS, Devi KP. Suganthy N, et al. Metab Brain Dis. 2016 Aug;31(4):937-49. doi: 10.1007/s11011-016-9831-0. Epub 2016 May 17. Metab Brain Dis. 2016. PMID: 27188290 - Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein.
Medeiros R, Prediger RD, Passos GF, Pandolfo P, Duarte FS, Franco JL, Dafre AL, Di Giunta G, Figueiredo CP, Takahashi RN, Campos MM, Calixto JB. Medeiros R, et al. J Neurosci. 2007 May 16;27(20):5394-404. doi: 10.1523/JNEUROSCI.5047-06.2007. J Neurosci. 2007. PMID: 17507561 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous